过度培养?SEP-1集束化启动后,急诊离院患者的血培养开具频率增加
该研究回顾性分析了2012年1月1日至2019年6月30日某郊区学术医院急诊离院成人患者的血培养开具情况,比较SEP-1指标实施前后每千名离院患者的血培养数量、病原体与污染菌阳性率,以及SEP-1相关化验(血培养、乳酸)与无关化验(D-二聚体、脂肪酶、人绒毛膜促性腺激素、脑钠肽)的开具变化。结果显示,血培养开具率从每1000名离院患者43.1次升至75.9次,增加76.2%(p<0.001);病原体阳性率从3.93%降至3.03%(p=0.044),污染菌阳性率从2.49%降至1.85%(p=0.071,无统计学差异);SEP-1相关化验平均增加81.0%,无关化验平均增加16.8%。作者认为,SEP-1指标可能产生了增加急诊离院患者血培养开具的非预期后果。
要点
- SEP-1实施后,急诊离院成人患者血培养开具率从43.1次/1000离院患者升至75.9次/1000离院患者,增加76.2%(p<0.001)。
- 离院患者血培养病原体阳性率从3.93%降至3.03%(p=0.044),污染菌阳性率从2.49%降至1.85%(p=0.071,无统计学差异)。
- SEP-1相关化验(血培养、乳酸)平均增加81.0%,无关化验(D-二聚体、脂肪酶、HCG、BNP)平均增加16.8%。
- 研究期间共144,343名成人从急诊离院,其中3,827次就诊共开具6,754次血培养。
- 作者认为SEP-1指标可能带来非预期后果,使足够健康可离院的患者血培养开具增多。
适用人群与场景
- 2012年1月1日至2019年6月30日期间,某郊区学术医院急诊离院的成人患者。
研究设计与关键结果
- 研究类型:回顾性评估;人群:某郊区学术医院急诊离院成人患者;时间:2012年1月1日至2019年6月30日。
- 研究期间共有144,343名成人从急诊离院,其中3,827次就诊共采集6,754次血培养。
- 血培养开具率从SEP-1指标前的43.1次/1000离院患者升至75.9次/1000离院患者,增加76.2%(p<0.001)。
- 血培养病原体阳性率从SEP-1前的3.93%降至SEP-1后的3.03%(p=0.044)。
- 血培养污染菌阳性率从SEP-1前的2.49%降至SEP-1后的1.85%(p=0.071)。
- SEP-1相关化验开具平均增加81.0%,SEP-1无关化验开具平均增加16.8%。
证据类型、等级与局限
- 证据类型:回顾性评估。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,SEP-1指标可能产生了增加急诊离院患者血培养开具的非预期后果。
- 作者认为,这些发现提示SEP-1指标使足够健康可离院的患者血培养开具增多,且该增加未伴随其他化验的类似增加。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: In 2015, the Severe Sepsis and Early Septic Shock Management Bundle (SEP-1) tied hospital reimbursement to performance on a series of time sensitive indicators, including ordering blood cultures on patients with severe sepsis or septic shock. This metric could have broadly shaped ordering practices in the Emergency Department (ED), including for patients who did not have severe sepsis or septic shock. In this study, we sought to evaluate whether the frequency of blood culture orders on adult patients discharged from the ED changed after the SEP-1 metric, whether the rates of positivity for pathogens or contaminants changed after the SEP-1 metric, and whether similar changes were seen in orders for other laboratory tests.
METHODS: This was a retrospective evaluation of blood culture orders from discharged adult ED patients from a suburban academic hospital between January 1, 2012 and June 30, 2019. We compared the number of blood cultures per discharged adult patient before and after the SEP-1 metric. We categorized each culture that grew an organism as a pathogen or a contaminant, and we compared rates of pathogen and contaminant growth before and after SEP-1. We compared rates of orders of blood cultures and lactates as labs related to SEP-1 with rates of orders of D-dimers, lipases, human chorionic gonadotropins (HCGs), and brain natriuretic peptides (BNPs) as labs unrelated to SEP-1 before and after the implementation of the SEP-1 metric.
RESULTS: There were 144,343 adult patients discharged from the ED during the study period. A total of 6754 blood cultures were drawn from 3827 of those patient visits. The rate increased from 43.1 cultures per 1000 discharged patients before the SEP-1 metric to 75.9 blood cultures per 1000 discharged patients, an increase of 76.2% (p < 0.001). The cultures had a decreased rate of positivity (from 3.93% before SEP-1 to 3.03% after SEP-1, p = 0.044) and an unchanged rate of blood cultures resulting in a contaminant (2.49% to 1.85%, p = 0.071). Overall, orders of the labs unrelated to SEP-1 increased by an average of 16.8% after the SEP-1 metric and orders of the labs related to SEP-1 increased by an average of 81.0%.
CONCLUSION: After the SEP-1 bundle, blood cultures were ordered more frequently on discharged ED patients. These cultures had a lower rate of positivity for pathogens and an unchanged rate of growth of contaminants. This increase was not matched by a similar increase in other labs. Taken together, these findings suggest that the SEP-1 metric had the unintended consequence of increasing orders of blood cultures on patients healthy enough to be discharged from the ED.
参考来源
- Sterk E, Wassermann T, Lamonge R, et al. Overcultured? Blood cultures on discharged ED patients were ordered more frequently after the SEP-1 bundle initiation. Am J Emerg Med. 2023. PMID: 36821960. doi:10.1016/j.ajem.2023.01.037
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。